Here's Why Pfizer And Novavax Shares Are Rising On Monday

Pfizer Inc. PFE and Novavax, Inc. NVAX shares are trading higher by 4.3% at $52.42 and 9.6% at $80.05 respectively. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.

A spike in COVID-19 cases has also caused some business operations to cease throughout China, and has in turn sent shares of several Chinese stocks lower for the session.

See Also: Here's Why Moderna Shares Are Rising On Monday

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). 

Novavax Inc is a biotechnology company that develops vaccines. 

Pfizer has a 52-week high of $61.71 and a 52-week low of $34.51.

Novavax has a 52-week high of $277.80 and a 52-week low of $65.82.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading IdeasSectorwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!